DN Decision Briefs / Platform evidence
Paradex classifies orders as Retail or Pro by submission method. That affects fees and execution conditions, while the reviewed collateral guide requires USDC for perpetual trading.
What Matters
Provider-documentation review focused on perpetual trading. Not an exhaustive product inventory, live execution test, security audit or individual eligibility assessment.
Do not treat Retail as a permanent identity. Check how each order is submitted, its resulting classification and the margin actually available.
DN Evidence Block
The guide classifies UI and interactive-JWT API submissions as Retail. Standard API submissions default to Pro; exceeding Retail limits changes treatment.
Why it matters: An automated route can change fee and execution conditions. Inspect the order classification, not an assumed permanent user category.
Paradex Retail and Pro ordersThe fee page lists zero Retail maker/taker trading fees and a separate Pro schedule. Pro perps/spot maker fees and volume-based taker fees apply.
Why it matters: A retail headline is not an API cost estimate. Confirm classification and discounts; no all-in cost is calculated here.
Paradex trading feesRetail orders have documented speed bumps and lower rate limits, with access to Retail Price Improvement liquidity and queue benefits. Pro orders follow different conditions.
Why it matters: Configuration differences do not establish which route fills better. DN has not performed comparable execution tests.
Paradex Retail and Pro ordersThe collateral guide says non-USDC balances contribute to total account value but not free collateral, and USDC is required for perpetual markets.
Why it matters: Do not count a non-USDC spot holding as available perp margin. The guide describes broader collateral support as future work.
Paradex non-USDC balances and collateralRisk checks constrain withdrawable USDC by free collateral and the account USDC balance. Margin-health checks govern liquidation eligibility.
Why it matters: Account value, free collateral and withdrawable funds are distinct. A displayed balance does not guarantee an immediate withdrawal of that amount.
Paradex risk checksThis review does not establish individual eligibility, API permission safety or live withdrawal and stop-loss reliability.
Why it matters: Check current terms and access controls separately. Provider documentation is not an independent safety endorsement.
Evidence boundary
No numerical all-in cost is calculated. A valid comparison needs contemporaneous quotes for matching assets, product modes, notional sizes, directions and holding periods, with entry, holding and exit costs included.
Your research record
The receipt preserves the provider sources and research gaps at version 1.0.0.
It is not a recommendation, approval, live quote or alert subscription. No account, balance, wallet or country is requested.
Change record
Initial documentation brief. Account-specific conditions and evidence limits are preserved in this version.
Review triggers: Changed official product, fee or margin documentation; A substantiated correction; The 14-day editorial review deadline. No automated provider surveillance runs for this brief.
Provider-reported describes the source of a statement, not an independent endorsement. Unknown and not measured identify evidence gaps. A documentation review does not confer an operational-status classification or establish user eligibility.
DN may receive compensation through commercial links elsewhere on the site. This brief contains no trading CTA or payout-based ranking. A documentation review does not establish current operational status or user eligibility.
Educational research only, not investment, legal or tax advice. Leveraged derivatives can cause substantial losses.
